Karl Baisch GmbH has been acquired by Friedrich Ziegler GmbH
Friedrich Ziegler GmbH, a manufacturer of furniture for a variety of industries such as medical rooms, kitchens and stores, has acquired the intangible assets of Karl Baisch GmbH within an asset deal. Financial details of this transaction have not been disclosed.
Karl Baisch GmbH is the leading manufacturer of dental furniture in Europe's German-speaking countries. The company has experienced financial difficulties for a number of years due to internal structural problems and the changing market environment. Despite the implementation of various measures to stabilise the business, the company has been unable to achieve a sustainable turnaround and was forced to file for insolvency.
Dr. Hendrik Hefermehl from Stuttgart has been appointed as the insolvency administrator.
Oaklins' team in Germany was commissioned exclusively by the insolvency administrator to provide assistance on the transfer of the company and its assets.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more